Avadel Pharmaceuticals plc (NASDAQ: AVDL) Stock Information | RedChip

Avadel Pharmaceuticals plc (NASDAQ: AVDL)


$11.6600
N/A ( +8.57% ) 1.6M

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

Market Data


Open


$11.6600

Previous close


$11.6600

Volume


1.6M

Market cap


$1.12B

Day range


$10.6780 - $11.7550

52 week range


$10.4100 - $19.0900

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Mar 04, 2024
4 Insider transactions 1 Mar 04, 2024
8-k 8K-related 16 Mar 04, 2024
8-k 8K-related 14 Mar 04, 2024
4 Insider transactions 1 Mar 04, 2024
10-k Annual reports 166 Feb 29, 2024
4 Insider transactions 1 Jan 16, 2024
8-k 8K-related 14 Jan 08, 2024
4 Insider transactions 1 Dec 29, 2023
10-q Quarterly Reports 73 Nov 08, 2023

Latest News